Session Type
Meeting
Search Results
Abstract Number: 115
SHM Converge 2023
Background: Anemia is an acute and/or chronic condition with a range of underlying etiologies present in an estimated 40-70% of hospitalized patients. While comprehensive diagnostic and treatment algorithms for anemia exist, they are rarely used by hospitalist clinicians in the inpatient setting. This is because these algorithms were derived in ambulatory patients where acute anemia […]
Abstract Number: 116
SHM Converge 2023
Background: Researchers across the globe have continued their effort in identifying important risk factors for severe COVID-19 infection. Patient demographics including age, race, gender, and certain chronic medical conditions including cardiovascular disease, diabetes, hypertension, and heart failure have been identified as the important risk factors for severity. To simply the risk stratification process, the CHA2DS2-VASc […]
Abstract Number: 117
SHM Converge 2023
Background: Proton pump inhibitors (PPIs) have been associated with adverse events and increased mortality in patients diagnosed with cirrhosis (1). PPIs are commonly prescribed to patients with cirrhosis who present to the hospital with gastrointestinal bleeds (2). However, guidelines do not suggest routine usage of PPI in patients with cirrhosis without gastroesophageal reflux disease (GERD) […]
Abstract Number: 119
SHM Converge 2023
Background: Since the implementation of the Hospital Readmission Reduction Program, 30-day readmissions have decreased across the U.S. regardless of hospital teaching intensity. The effect of financial penalties on long term readmission rates has not been studied. Teaching hospitals serve as leaders in medical education, research, innovation, and patient care. Therefore, we examined whether long-term readmission […]
Abstract Number: 120
SHM Converge 2023
Background: COVID-19 pandemic was vital in modifying healthcare delivery systems. This infection has led to variable composite outcomes in patients who have cardiovascular diseases [1,2]. In this study, we aimed to look into the impact of COVID-19 on incidence and outcomes of patients with Acute Myocardial Infarction using a nationally representative sample from the USA. […]
Abstract Number: 121
SHM Converge 2023
Background: Diabetic Ketoacidosis (DKA) is the most common severe acute complication of diabetes, and has shown to be worsened by COVID-191. Several studies have found an association between COVID-19 and worsened outcomes from diabetic ketoacidosis (DKA).2 Vaccination against COVID-19 has led to substantial declines in the frequency, severity, and mortality from acute infection, but little […]
Abstract Number: 122
SHM Converge 2023
Background: High health care costs and poor outcomes are associated with high hospitalization rates and are concentrated in a small fraction of the population. Fragmented patient care and socioeconomic disadvantage may further increase hospitalization rates. To defragment medical care for a socioeconomically diverse population of Medicare patients at increased risk of hospitalization, the University of […]
Abstract Number: 123
SHM Converge 2023
Background: The presence of concomitant diabetic ketoacidosis (DKA) with acute pancreatitis (AP) is not uncommon and is associated with unfavorable outcomes (1,2). However, the diagnosis of AP in DKA patients is often missed because of the overlapping clinical features. Data comparing clinical characteristics and outcomes of patients with co-existing DKA and AP with DKA alone […]
Abstract Number: 124
SHM Converge 2023
Background: Axial spondyloarthritis (axSpA) takes two forms – radiographic (also known as ankylosing spondylitis(AS)) and non-radiographic (nr-axSpA). The symptoms caused are similar with chronic back pain, but nr-axSpA damage cannot be seen on X-rays. Historically, nonradiographic axial spondyloarthritis (nr-axSpA) did not have any approved codes so clinicians had to use AS and other codes. Starting […]
Abstract Number: 125
SHM Converge 2023
Background: Antibiotics used to treat Clostridioides difficile infection (CDI) can predispose patients to recurrent CDI (rCDI). Gut microbiome restoration by fecal microbiota transplantation is recommended by multiple guidelines after ≥2 episodes of rCDI, with no guideline-recommended options to restore the microbiome earlier in the course of CDI. RBX2660 is a standardized, microbiota-based live biotherapeutic being […]